Pharmaceutical company Pneuma Respiratory Inc revealed on Friday the addition of shareholder J. Knox Singleton to its board of directors.
Singleton has served for 35 years as the CEO of Inova Health System, the largest employer in Northern Virginia, until his retirement in July 2018.
Previously, Singleton received numerous awards during his career in recognition of his leadership in the field of health care.
According to the company, Singleton is a Phi Beta Kappa graduate of the University of North Carolina, where he earned a Bachelor of Science Degree in Business Administration and he holds a Master's Degree in Health Administration from Duke University.
Dizal meets primary endpoint in Phase 3 study of ZEGFROVY (sunvozertinib) monotherapy
bioMérieux secures IVDR CE marking for respiratory diagnostic panels in Europe
Avacta opens Phase 1 trial for AVA6103 cancer therapy in US
IDEAYA Biosciences enrols first patient in Phase 1 trial of PRMT5 inhibitor IDE892
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
Novartis to build new radioligand therapy site in Texas
GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline
Epredia signs EU distribution deal with Mindpeak for AI pathology software
Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH